Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study

Roland Stocker, Christine Pollicino, Craig Gay, Paul Nestel, David Colquhoun, Malcolm Whiting, Andrew Tonkin, David Sullivan, John Simes

    Research output: Contribution to journalArticle

    17 Citations (Scopus)
    Original languageEnglish
    Article numberCC
    Pages (from-to)198-204
    Number of pages7
    JournalAtherosclerosis
    Volume187
    Issue number1
    Publication statusPublished - 2006

    Cite this

    Stocker, R., Pollicino, C., Gay, C., Nestel, P., Colquhoun, D., Whiting, M., Tonkin, A., Sullivan, D., & Simes, J. (2006). Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. Atherosclerosis, 187(1), 198-204. [CC].